Abstract
In the drug discovery cascade, metabolism studies should be performed as early as possible to allow an early evaluation of the metabolism profiles of drug candidates. To help design new drug candidates with improved pharmacokinetics, the knowledge of the site of metabolism is necessary. Computational or in silico metabolism approaches can be broadly classified into (i) ligand-based methods, and (ii) structure-based methods. This review highlight tools used to predict P450-mediated metabolism including ligand-based and structure-based approaches. Some examples of successful application of an integrated in silico approach for the prediction of Phase I metabolism for some flavonoids and lead compounds are presented. Moreover, an integrated in silico approach for the prediction of P450- mediated metabolism is described.
Keywords: Cytochrome P450, docking, drug discovery, ligand-based, metabolism, prediction, structure-based.
Current Drug Metabolism
Title:In silico Prediction of Drug Metabolism by P450
Volume: 15 Issue: 5
Author(s): Carolina H. Andrade, Diego C. Silva and Rodolpho C. Braga
Affiliation:
Keywords: Cytochrome P450, docking, drug discovery, ligand-based, metabolism, prediction, structure-based.
Abstract: In the drug discovery cascade, metabolism studies should be performed as early as possible to allow an early evaluation of the metabolism profiles of drug candidates. To help design new drug candidates with improved pharmacokinetics, the knowledge of the site of metabolism is necessary. Computational or in silico metabolism approaches can be broadly classified into (i) ligand-based methods, and (ii) structure-based methods. This review highlight tools used to predict P450-mediated metabolism including ligand-based and structure-based approaches. Some examples of successful application of an integrated in silico approach for the prediction of Phase I metabolism for some flavonoids and lead compounds are presented. Moreover, an integrated in silico approach for the prediction of P450- mediated metabolism is described.
Export Options
About this article
Cite this article as:
Andrade H. Carolina, Silva C. Diego and Braga C. Rodolpho, In silico Prediction of Drug Metabolism by P450, Current Drug Metabolism 2014; 15 (5) . https://dx.doi.org/10.2174/1389200215666140908102530
| DOI https://dx.doi.org/10.2174/1389200215666140908102530 |
Print ISSN 1389-2002 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Innovative Therapeutic Approaches in Infectious Diseases
Infectious diseases continue to challenge global health systems due to rising antimicrobial resistance, emerging pathogens, and increasing drug tolerance. This special issue aims to move beyond traditional approaches by exploring innovative pharmacological strategies for the treatment of infectious diseases. We welcome original research and reviews ranging from clinical trials and ...read more
Pharmacokinetics of Nanocarriers: Challenges, Innovations, and Translational Perspectives
This thematic issue will focus on the evolving field of nanocarrier-based drug delivery systems and their pharmacokinetic behavior. Understanding the ADME (Absorption, Distribution, Metabolism, and Excretion) properties of nanoparticles is crucial for optimizing therapeutic efficacy and minimizing systemic toxicity. The issue will highlight the influence of nanocarrier physicochemical properties (size, ...read more
Unveil the Potential of Functional Framework Nucleic Acids in Theranostics
Nanomedicine demonstrates remarkable potential in disease diagnosis and treatment by precisely manipulating the physicochemical properties of materials on the nanometer scale. Its advantages as nanocarriers include high loading capacity, prolonged in vivo half-life and controllable targeted delivery. However, existing vectors (such as liposomes, polymers, and inorganic particles) still face significant ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Applications for Invasive and Non-invasive Tools in the Era of Contemporary
Percutaneous Coronary Revascularisation
Current Cardiology Reviews Targeted Drug Delivery for Breast Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry Effects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic Angina
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Salvaging the Ischemic Heart: Gi-Coupled Receptors in Mast Cells Activate a PKCε/ALDH2 Pathway Providing Anti-RAS Cardioprotection
Current Medicinal Chemistry Catecholamines, Sympathetic Innervation and Immunity: Role in Experimental and Rheumatoid Arthritis
Letters in Drug Design & Discovery Tramadol Induced QTc-Interval Prolongation: Prevalence, Clinical Factors and Correlation to Plasma Concentrations
Current Drug Safety Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
Current Pharmaceutical Design Recent Advances in the Synthesis of 1,3-Azoles
Current Topics in Medicinal Chemistry Refined Purification of Large Amounts of Rat cvHsp/HspB7 and Partial Biological Characterization In Vitro
Protein & Peptide Letters MicroRNAs in Genetic Disease: Rethinking the Dosage
Current Gene Therapy Antisense Strategies
Current Molecular Medicine Angiotensin (1-7) and other Angiotensin Peptides
Current Pharmaceutical Design MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Cardiac Disease
Recent Patents on Biomarkers Patent Selections
Recent Patents on Medical Imaging Molecular Genetics of Polycystic Ovary Syndrome: An Update
Current Molecular Medicine Apoptosis in the Homeostasis of the Immune System and in Human Immune Mediated Diseases
Current Pharmaceutical Design What Restricts the Clinical Use of Nicotinic Acid?
Current Vascular Pharmacology Drug Development and the Importance of Ethnicity: Lessons from Heart Failure Management and Implications for Hypertension
Current Pharmaceutical Design Inhibition of Matrix Metalloproteinases (MMPs) as a Potential Strategy to Ameliorate Hypertension-Induced Cardiovascular Alterations
Current Drug Targets





